Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Eli Lilly and Company
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
chronickidneydiseaseobesity
type 2 diabetes, obesity, overweight or obesity, overweight, cardiovascular diseases, chronic kidney disease
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 373736
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.